Latest Administration News

Infinity Metals continues to push forward with exploration in Australia while awaiting critical mining licence feedback for its San Jose Lithium Project in Spain amid regional government delays.

Volt Group’s first quarter of FY26 saw ordinary revenue receipts surge 150% year-on-year to $3 million, driven by the integration of 4D Delta and strong contributions from its subsidiaries Wescone and EcoQuip.

Macallum New Energy has successfully listed on the ASX and raised A$7.4 million to fund exploration in the Northern Perth Basin. The company is progressing a 66% complete Barberton 3D seismic survey and preparing a Condor 2D survey, positioning itself amid renewed regional drilling activity.

EBR Systems secures Priority Review from Australia's TGA for its wireless cardiac pacing system, fast-tracking regulatory approval and expanding access for heart failure patients. This follows strong US commercial momentum after FDA approval.

Askari Metals has completed data compilation at its Nejo Gold and Copper Project, setting the stage for a 5,000m maiden drilling campaign targeting high-grade gold and copper. Meanwhile, trenching at its Uis Project in Namibia reveals robust polymetallic mineralisation, including tin, tantalum, lithium, rubidium, and caesium, underpinning plans for RC drilling later this year.

Brazilian Critical Minerals (ASX: BCM) has reinforced the scale and quality of its Ema rare earth project with strong drilling results and steady progress on permitting and feasibility studies, positioning it well amid tightening global supply.

Cycliq Group’s Q3 FY2026 customer receipts fell 23% year-on-year to $561k, though a late March UpRide Birthday campaign injected $256k in revenue. Operating cash outflows reflect prior quarter cost settlements, with hopes for cost normalisation and sales momentum in Q4.

Tesoro Gold has reported standout deep drilling results at its Ternera Deposit, confirming mineralisation well beyond previous open pit limits, while fast-tracking its El Zorro project into a Definitive Feasibility Study aiming for completion by year-end.

Cambium Bio has secured FDA confirmation that a single pivotal Phase 3 trial plus confirmatory evidence will suffice for Biologics License Application submission for Elate Ocular, significantly reducing development expenses and accelerating the pathway to market.

InVert Graphite has delivered strong assay results from its maiden drilling program at the Morogoro Project, Tanzania, confirming extensive near-surface graphite mineralisation with grades up to 21.5% Total Graphitic Carbon. The company pauses drilling for the wet season but maintains a solid cash position to advance next steps.

8common Limited reported a 7% rise in SaaS revenue to $1.2 million in Q3 FY26, backed by fresh government contracts and cost cuts. The fintech is on track to deliver full year EBITDA positive and maintain solid operational cash flow.

DigitalX Limited closed the March 2026 quarter with A$59.5 million in liquid assets, unveiling a A$30 million strategic investment program and delivering record revenue from its Sell My Shares platform, signalling a pivot towards disciplined capital deployment and sustainable growth.